Clinical and Angiographic Outcomes of the First Korean-made Sirolimus-Eluting Coronary Stent with Abluminal Bioresorbable Polymer.
Yang HM, Seo KW, Yoon J, Kim HS, Chang K, Lim HS, Choi BJ, Choi SY, Yoon MH, Lee SH, Ahn SG, Youn YJ, Lee JW, Koo BK, Park KW, Yang HM, Han JK, Seung KB, Chung WS, Kim PJ, Koh YS, Park HJ, Tahk SJ.
Yang HM, et al. Among authors: kim pj.
Korean Circ J. 2017 Nov;47(6):898-906. doi: 10.4070/kcj.2017.0094. Epub 2017 Sep 18.
Korean Circ J. 2017.
PMID: 29035435
Free PMC article.
RESULTS: We enrolled 38 patients for the Genoss DES group and 39 patients for the Promus Element group. In-stent late lumen loss at 9 months was not significantly different between the 2 groups (0.110.25 vs. 0.160.43 mm, p=0.567). ...CONCLUSION: This first-in-patient study …
RESULTS: We enrolled 38 patients for the Genoss DES group and 39 patients for the Promus Element group. In-stent late lumen loss at 9 …